A comparison of the oral application and injection routes using the onderstepoort biological products fowl typhoid vaccine, its safety, efficacy and duration of protection in commercial laying hens.
This study was undertaken to establish whether the Onderstepoort Biological Products Fowl Typhoid (OBPft) vaccine registered as an injectable vaccine was effective and safe when administered orally to commercial layers. Its efficacy and duration of protection were compared with application by intramuscular injection. Commercial brown layer hens were used as they were found to be highly susceptible to Salmonella gallinarum infections. In the vaccine safety trial birds were euthanased at timed intervals spanning 4 weeks postvaccination. Necropsies were performed and samples were taken and tested. No clinical signs or mortalities could be attributed to the OBPft vaccine nor could active shedding of the vaccine strain be detected. Slight pathological changes were noted with both routes of vaccination; however, these changes were transient, returning to normal within the observation period. The injected groups showed a better serological response with the rapid serum plate agglutination (RSPA) test than the orally vaccinated groups. In the duration of protection trial, birds were challenged at 3-8-week intervals post-vaccination. All unvaccinated birds died. Protection 8 and 16 weeks after vaccination was above 60 %,by 24 weeks after challenge, the vaccine protection was below 30 %. It was found that there was no significant difference (P < 0.05) in the protection offered by either the oral or injected route of vaccination with the OBPft vaccine.
Purchase
C
C
Department of Zoology and Entomology, University of Pretoria, Pretoria, 0002 South Africa. cpurchase@zoology.up.ac.za
Picard
J
J
McDonald
R
R
Bisschop
S P R
SP
D000284:Administration, Oral; D000818:Animals; D002645:Chickens; D015169:Colony Count, Microbial / Q000662:veterinary; D005243:Feces / Q000382:microbiology; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D010058:Oviposition; D011201:Poultry Diseases / Q000517:prevention & control*; D011897:Random Allocation; D012449:Safety; D012481:Salmonella Infections, Animal / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*
D014436:Typhoid-Paratyphoid Vaccines